Categories List
Payment Methods
Shipping Option
Shopping cart
People who bought this, also bought:
Microzide is a diuretic used to lower blood pressure and prevent heart attacks, strokes, and kidney problems.
$0.50
Buy now
Norvasc is a calcium channel blocker prescribed to treat hypertension, ischemic heart disease, angina.
$0.45
Buy now
Aldactone is a diuretic (water pill) indicated to treat hypertension, fluid retention associated with congestive heart failure, cirrhosis, and nephrotic syndrome.
$0.38
Buy now
Inderal is a beta-adrenergic receptor blocker and is used to treat angina, hypertension and heart rhythm disorders.
$0.33
Buy now
Aceon an angiotensin-converting enzyme inhibitor is used to control hypertension and to prevent heart attack in patients with coronary artery disease
$1.06
Buy now
Wellbutrin SR is an antidepressant from aminoketone class prescribed to relieve major depression.
$0.99
Buy now
Plavix prevents formation of blood clots and is prescribed to reduce the risk of circulation problems, stroke and heart attack.
$0.62
Buy now
Testimonials
Alan Durk
It is so convenient to buy through the site, there are many convenient mechanisms to place an order. When I could not understand the mode to fill up my cart I phoned customer support and was followed through ... Tom, Clearwater
Dear customer support, I finally received my package yesterday. And, all is good. It took its time getting here, but it made it. 
Social bookmarks
News
Cost of children's homes doubles but care can be poor, says report
Huge sums spent on children's residential care in England do not represent value for money, says spending watchdog. What the NHS can learn from the European country that helped more people survive cancer
Denmark's survival rates record for certain cancers were poor compared to some other wealthy countries. Then it came up with a bold plan Doctors warn hospitals under pressure as NHS waiting lists rise
The waiting list for planned hospital treatment in England rose for the second month in a row in July to its highest level since March. Postcode lottery for new cancer treatments, doctors warn
Experts say bureaucracy is "stifling innovation" and that applying for funding to pay for new treatments can be "cumbersome".